MDxHealth SA (MDXH) Misses Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- AI warnings knock Nasdaq futures, pressure tech stocks
- AI-linked stocks slump after top lab CEOs call for slowing technology's development
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Goldman Sachs tech conference highlights AI spending outlook
- Dell shares surge on record AI server bookings
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- 'No panic anywhere' may be the problem, BofA strategists warn
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
BTIG Reiterates Buy Rating on MDxHealth SA (MDXH)
August 23, 2024 5:05 AM EDTBTIG analyst Mark Massaro reiterated a Buy rating and $8.00 price target on MDxHealth SA (NASDAQ: MDXH)
The analyst comments "As pre-announced, MDXH reported a Q2 revenue beat and raised its 2024 revenue guide slightly in excess of the beat, marking another solid quarter of... More
